Ht-Logo-gigapixel-icon
  • Menu
Search
Close this search box.
  • News
  • Opinion
  • Archives
  • Politics
  • Foreign Policy
  • Lobbying
  • Legislation
  • Policy
  • Hill Life & People
  • Podcast
  • News
  • Opinion
  • Archives
  • Politics
  • Foreign Policy
  • Lobbying
  • Legislation
  • Policy
  • Hill Life & People
  • Podcast
  • Free Trial
  • Get free News Updates
  • SIGN IN
  • SUBSCRIBE
  • Free Trial
  • Get free News Updates
  • SIGN IN
  • SUBSCRIBE
  • Get free News Updates
  • {email}
    • Administration
    • Account Settings
    • Logout
  • SUBSCRIBE
  • Get free News Updates
  • {email}
    • Administration
    • Account Settings
    • Logout
  • SUBSCRIBE
Ht-Logo-gigapixel-icon
  • Menu
Search
Close this search box.
  • Home Page
  • News
  • Opinion
  • Foreign Policy
  • Politics
  • Policy
  • Legislation
  • Lobbying
  • Hill Life & People
  • Hill Climbers
  • Heard On The Hill
  • Calendar
  • Archives
Menu
  • Home Page
  • News
  • Opinion
  • Foreign Policy
  • Politics
  • Policy
  • Legislation
  • Lobbying
  • Hill Life & People
  • Hill Climbers
  • Heard On The Hill
  • Calendar
  • Archives
My Account
  • Free Trial
  • Sign in
  • Free Trial
  • Sign in
  • Free Trial
  • Sign in
  • Free Trial
  • Sign in
Thursday, November 21, 2024
Canada’s Politics and Government News Source Since 1989
Latest Paper
Thursday, November 21, 2024 | Latest Paper
Subscribe Now

TRENDING:

  • Labour
  • Heard on the Hill
  • de Adder
  • Calendar
  • Party Central
  • Public service
    • Lori Turnbull
  • Trump 2.0
    • Josie Sabatino
    • Lobbying
  • Labour
  • Heard on the Hill
  • de Adder
  • Calendar
  • Party Central
  • Public service
    • Lori Turnbull
  • Trump 2.0
    • Josie Sabatino
    • Lobbying

Pharmacare bill offers too much ambiguity and too little ambition

To understand and maximize value, we should know why the government chose this odd-duck model, and diabetes and contraception drugs over others. Politics over public health, perhaps?

Mark Holland
Health Minister Mark Holland has suggested the national pharmacare plan would initially cost about $1.5-billion annually, but that depends on the scope and pace of those bilateral agreements, writes Chris Bonnett. The Hill Times photograph by Andrew Meade
Opinion
BY CHRIS BONNETT
April 10, 2024
Opinion | BY CHRIS BONNETT | April 10, 2024

Sponsored content

Canada’s aging crisis and a call for reform in eldercare

sponsored content
elderly-01

Canada’s aging crisis and a call for reform in eldercare

Get The Weekend Point of View Newsletter

Top Canadian political and policy opinion and analysis. Saturdays and Sundays. Weekends.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy

More Opinion

Justin Trudeau

As COP29 wraps up, will Canada finally stop funding fossils this fall?

OpinionBY JULIA LEVIN

Addressing the threat of antimicrobial resistance

OpinionBY INDEPENDENT SENATOR MOHAMED-IQBAL RAVALIA
Pierre Poilievre

The wisdom of Homer Simpson and Aaron Sorkin

OpinionBY JAMIE CARROLL

Climate finance should target resilient food systems

OpinionBY CAROL THIESSEN

Trump’s ‘America First’ plans may undermine global trade

OpinionBY ANDREW CADDELL

Related Stories

New Democratic Party leader Jagmeet Singh speaks with reporters in the House of Commons foyer before Question Period on June 3, 2024, about the upcoming vote on the government’s pharmacare bill.

The NDP-backed pharmacare plan is a corporate handout as written

OpinionBY STEVE MORGAN, MATTHEW HERDER, NAV PERSAUD
Mark Holland

Pharmacare bill and Liberal messaging at odds, confusing stakeholders on vision for ‘single-payer’ system

NewsBY TESSIE SANCI

Next step in universal drug coverage should prioritize ‘essential medicines,’ says pharmacare expert

NewsBY JESSE CNOCKAERT
Mark Holland

Budget’s ‘slow rollout’ pharmacare funding leaves program vulnerable to change in governments, say policy experts

NewsBY IAN CAMPBELL

Feds must expand pharmacare to include essential drugs for our deadliest diseases: cancer, heart conditions, and stroke

OpinionBY ANDREA SEALE, DOUG ROTH

News

  • Politics
  • Foreign Policy
  • Lobbying
  • Legislation
  • Policy Briefings
  • Politics This Morning
  • Hill Climbers
  • Civil Circles
  • Heard On The Hill
  • Election
  • Finance and Budget
  • Public Service
  • Exclusive Lists
  • Parliamentary Calendar
  • Top 100 Lists and Exclusive Features
  • Podcasts
  • This Week's Paper
  • Search
  • Archives
  • Digital Newspaper Archives

Get free news updates

Opinion

  • Andrew Caddell
  • Sheila Copps
  • David Crane
  • Jim Creskey
  • Gwynne Dyer
  • Michael Harris
  • Erica Ifill
  • Scott Taylor
  • Joe Jordan
  • Rose LeMay
  • Alex Marland
  • Gerry Nicholls
  • Gar Pardy
  • Tim Powers
  • Susan Riley
  • Douglas Roche
  • Ken Rubin
  • Bhagwant Sandhu
  • Les Whittington

Submit a guest opinion article

resources

  • The Wire Report
  • Hill Times Research Health
  • The Lobby Monitor
  • Parliament Now
  • Inside Ottawa Directory
  • Hill Times Careers
  • The Hill Times Store
  • Digital Newspaper Archives

Advertise

  • Media Kit

subscribe

  • Group subscriptions
  • Reuse and permissions

get help

  • About us
  • Contact us
  • Privacy Policy
  • Reset Password
  • Account settings
  • © The Hill Times 2024
  • Politics
  • Foreign Policy
  • Lobbying
  • Legislation
  • Policy Briefings
  • Politics This Morning
  • Hill Climbers
  • Civil Circles
  • Heard On The Hill
  • Election
  • Finance and Budget
  • Public Service
  • Exclusive Lists
  • Parliamentary Calendar
  • Top 100 Lists and Exclusive Features
  • Podcasts
  • This Week's Paper
  • Search
  • Archives
  • Digital Newspaper Archives

  • Get free news updates

  • Andrew Caddell
  • Sheila Copps
  • David Crane
  • Jim Creskey
  • Gwynne Dyer
  • Michael Harris
  • Erica Ifill
  • Scott Taylor
  • Joe Jordan
  • Rose LeMay
  • Alex Marland
  • Gerry Nicholls
  • Gar Pardy
  • Tim Powers
  • Susan Riley
  • Douglas Roche
  • Ken Rubin
  • Bhagwant Sandhu
  • Les Whittington

  • Submit a guest opinion article

  • The Wire Report
  • Hill Times Research Health
  • The Lobby Monitor
  • Parliament Now
  • Inside Ottawa Directory
  • Hill Times Careers
  • The Hill Times Store
  • Digital Newspaper Archives
  • Media Kit
  • Group subscriptions
  • Reuse and permissions
  • About us
  • Contact us
  • Privacy Policy
  • Reset Password
  • Account settings
  • © The Hill Times 2024
Subscribe
  • Home Page
  • News
  • Opinion
  • Foreign Policy
  • Politics
  • Policy
  • Legislation
  • Lobbying
  • Hill Life & People
  • Hill Climbers
  • Heard On The Hill
  • Calendar
  • Archives
  • Home Page
  • News
  • Opinion
  • Foreign Policy
  • Politics
  • Policy
  • Legislation
  • Lobbying
  • Hill Life & People
  • Hill Climbers
  • Heard On The Hill
  • Calendar
  • Archives
  • Inside Ottawa Directory
  • Hill Times Store
  • Hill Times Careers
  • The Wire Report
  • The Lobby Monitor
  • Parliament Now
  • Inside Ottawa Directory
  • Hill Times Store
  • Hill Times Careers
  • The Wire Report
  • The Lobby Monitor
  • Parliament Now
  • Reuse & Permissions
  • Advertising
  • Reuse & Permissions
  • Advertising
  • Contact Us
  • Log In
  • Logout
  • Contact Us
  • Log In
  • Logout
CloseMenu
  • {email}
  • Account Settings
  • Logout
  • {email}
  • Account Settings
  • Logout